Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Masha Frenkel"'
Autor:
Gady Cojocaru, Tal Fridman Kfir, Eran Ophir, Zoya Alteber, Pierre Ferre, Masha Frenkel, Assaf Menachem, Dan Blat, Olga Leiderman, Moran Galperin, Lital Sever, Nadav Cohen, Keren Cohen, Roy Granit, Sandra Vols, Lior Faigenbloom, Liron Soffer, Karin Meyer, Keren Menachem, Hadas Galon Tilleman, Michal Perpinial, Evgeny Tatirovsky
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/1a9f382ede6b446a84d8e97f71a1e662
Autor:
Gady Cojocaru, Amit Novik, Zurit Levine, Eran Ophir, Zoya Alteber, Masha Frenkel, Emmanuel Weyl, Niv Sabath, Assaf Wool, Yossef Kliger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/cff3089dcd4446308dd9835c9333a66e
Autor:
Gady Cojocaru, Margaret L. Tang, Patrick Wall, Sandeep Kumar, Eran Ophir, Hsin-Yuan Cheng, John J. Hunter, Ling Leung, Andrew W. Drake, Maya F. Kotturi, Masha Frenkel, Kathryn Logronio, David Bernados, Moran Galperin, Kyle Hansen, Spencer Liang, Samir Qurashi, Mark A. White, Zoya Alteber, Sarah Whelan
Publikováno v:
Cancer Immunology, Immunotherapy. 70:3525-3540
Immune checkpoint inhibitors (ICIs) have emerged as promising therapies for the treatment of cancer. However, existing ICIs, namely PD-(L)1 and CTLA-4 inhibitors, generate durable responses only in a subset of patients. TIGIT is a co-inhibitory recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3956f7736390726882c24308715f5566
https://doi.org/10.1007/s00262-021-02921-8
https://doi.org/10.1007/s00262-021-02921-8
Autor:
Masha Frenkel, Zoya Alteber, Ning Xu, Mingjie Li, Haiming Chen, Gady Cojocaru, James Berenson, Eran Ophir
Publikováno v:
Cancer Research. 82:610-610
Blocking inhibitory immune receptors has shown limited clinical benefit in patients with multiple myeloma (MM), warranting the discovery of alternative immune inhibitory pathways. Blockade of the immune checkpoint TIGIT was shown to enhance anti-tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c980bf52d9979981358f0930f9080f83
https://doi.org/10.1158/1538-7445.am2022-610
https://doi.org/10.1158/1538-7445.am2022-610
Autor:
Masha Frenkel, Niv Sabath, Zurit Levine, Gady Cojocaru, Assaf Wool, Zoya Alteber, Emmanuel Weyl, Eran Ophir, Amit Novik, Yossef Kliger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundT-cell accumulation in tumors is a prerequisite for response to cancer immunotherapy. Recent studies highlighted the importance of an early-memory (stem-like) T-cell sub-population, that can self-renew and differentiate into effector cells,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b738d73f4f4b3dcb3454ba540ea20f44
https://doi.org/10.1136/jitc-2021-sitc2021.252
https://doi.org/10.1136/jitc-2021-sitc2021.252
Autor:
Ning Xu, James R. Berenson, Gady Cojocaru, Masha Frenkel, Haiming Chen, Eran Ophir, Mingjie Li, Zoya Alteber
Publikováno v:
Blood. 138:4717-4717
Introduction Blocking inhibitory immune checkpoints holds promise to treat multiple myeloma (MM) patients. However, currently available checkpoint inhibitors have not shown significant clinical benefits for MM patients, warranting the need for altern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::766575784c817fac0544149df9a8d00c
https://doi.org/10.1182/blood-2021-148052
https://doi.org/10.1182/blood-2021-148052